You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rAvPAL-PEG

Showing 1 - 25 of 884
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Phenylketonuria Trial in United States (rAvPAL-PEG)

Completed
Has Results
  • Phenylketonuria
  • rAvPAL-PEG
  • Aurora, Colorado
  • +13 more
Sep 15, 2021

Phenylketonuria (PKU) Trial in United States (Pegvaliase)

Completed
Has Results
  • Phenylketonuria (PKU)
  • Gainesville, Florida
  • +16 more
Feb 16, 2022

Phenylketonuria Trial in United States (BMN 165 (rAvPAL-PEG))

Completed
Has Results
  • Phenylketonuria
  • BMN 165 (rAvPAL-PEG)
  • Aurora, Colorado
  • +5 more
Jul 23, 2019

Phenylketonuria Trial in United States (rAvPAL-PEG 0.001 mg/kg, rAvPAL-PEG 0.003 mg/kg, rAvPAL-PEG 0.01 mg/kg)

Completed
Has Results
  • Phenylketonuria
  • rAvPAL-PEG 0.001 mg/kg
  • +4 more
  • Aurora, Colorado
  • +10 more
Feb 4, 2019

Phenylketonuria Trial in United States (rAvPAL-PEG)

Completed
Has Results
  • Phenylketonuria
  • rAvPAL-PEG
  • Aurora, Colorado
  • +8 more
Feb 4, 2019

PEGylated GH for Treatment of Short Stature in Chinese

Recruiting
  • Growth Hormone Treatment
  • Growth Disorders
  • Polyethylene glycol recombinant human growth hormone injection
  • Beijing, Beijing, China
    Department of Endocrinology, Genetics, Metabolism
Sep 12, 2023

Predictive Models of Inadequate Colonic Preparation

Not yet recruiting
  • Cleansing Quality of the Colon
  • Bowel preparation for colonoscopy
  • Colonoscopic examination
  • (no location specified)
May 13, 2023

Colonoscopy Trial in Chendu (100 ml lactulose combined with 1 L PEG, 100 ml lactulose combined with 2 L PEG, 200 ml lactulose)

Completed
  • Colonoscopy
  • 100 ml lactulose combined with 1 L PEG
  • +3 more
  • Chendu, Sichuan, China
    west china fourth hospital of Sichuan university
Dec 29, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in Taiwan (ADI-PEG20, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Kaohsiung, Taiwan
  • +4 more
Apr 24, 2023

Pediatric Growth Hormone Deficiency (PGHD) Trial in Chengdu (PEG-rhGH with new preparation, PEG-rhGH with present preparation)

Not yet recruiting
  • Pediatric Growth Hormone Deficiency (PGHD)
  • PEG-rhGH with new preparation
  • PEG-rhGH with present preparation
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Nov 12, 2023

Pediatric Growth Hormone Deficiency (PGHD) Trial in Chengdu (PEG-rhGH with new preparation, PEG-rhGH with present preparation)

Not yet recruiting
  • Pediatric Growth Hormone Deficiency (PGHD)
  • PEG-rhGH with new preparation
  • PEG-rhGH with present preparation
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Nov 12, 2023

Polyethylene Glycols, Children, Only Trial (PEG 3350)

Not yet recruiting
  • Polyethylene Glycols
  • Children, Only
  • PEG 3350
  • (no location specified)
Jul 28, 2022

Artificial Intelligence and Bowel Cleansing Quality

Recruiting
  • Cleansing Quality of the Colon
  • Bowel preparation for colonoscopy
  • Colonoscopy
  • La Laguna, S/C De Tenerife, Spain
    Department of Gastroenterology
Jan 13, 2023

Dysphagia, QoL and Attitudes Towards PEG in ALS Patients

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • Iowa Oral Performance Instrument (IOPI)
  • +3 more
  • Ljubljana, Slovenia
    University Medical Centre Ljubljana
Jul 1, 2022

Lymphoma Trial in Chongqing (PEG-rhG-CSF, RhG-CSF)

Recruiting
  • Lymphoma
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Aug 31, 2023

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • pegylated recombinant human granulocyte-colony stimulating factor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Sep 23, 2023

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Colonic Tumors Trial in Hangzhou (Lactulose oral solution, PEG)

Completed
  • Colonic Neoplasms
  • Lactulose oral solution
  • PEG
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Dec 5, 2022

Chronic Hepatitis B Virus Infection Trial in Worldwide (PEG-IFNa, BRII-835)

Not yet recruiting
  • Chronic Hepatitis B Virus Infection
  • Kingswood, New South Wales, Australia
  • +28 more
Jul 21, 2023

Crohn Disease, Ultrasound Therapy; Complications, Computed Tomography Trial in Hyderabad (Small intestinal contrast enhanced

Recruiting
  • Crohn Disease
  • +3 more
  • Small intestinal contrast enhanced ultrasound followed by Computed tomography/Magnetic resonance enterography
  • Hyderabad, Telangana, India
    Asian Institute of Gastroenterology
Nov 5, 2023

1L-PEG-Asc Solution for Bowel Preparation in"Open Access"

Completed
  • Bowel Preparation
  • use of a very low-volume 1L-PEG plus ascorbate (plenvu) or low-volume 2L-PEG plus ascorbate (moviprep) for bowel preparation in open access colonoscopy
  • Carpi, Modena, Italy
    Azienda USL Modena
Feb 15, 2022

Small Cell Lung Cancer Trial in Worldwide (ADI-PEG 20 (Arginine deiminase pegylated))

Terminated
Has Results
  • Small Cell Lung Cancer
  • ADI-PEG 20 (Arginine deiminase pegylated)
  • New York, New York
  • +7 more
Oct 3, 2022

Metastatic Melanoma, Skin Cancer, Tumor Trial in New York (ADI PEG 20)

Completed
Has Results
  • Metastatic Melanoma
  • +2 more
  • ADI PEG 20
  • New York, New York
  • +1 more
Oct 3, 2022

Gender Dysphoria Trial in Nashville (Polyethylene Glycol 3350)

Recruiting
  • Gender Dysphoria
  • Polyethylene Glycol 3350
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 1, 2023